Maxine Gowen
Director · 2 filings · Latest: Jun 4, 2026
Aclaris Therapeutics, Inc.
Passage BIO, Inc.
| Ticker | Owner | Relationship | Date | Transaction | Cost | #Shares | Value ($) | #Shares Total | SEC Form 4 |
|---|---|---|---|---|---|---|---|---|---|
ACRS | Maxine Gowen | Director | Jun 5, 2026 | Option Exercise | — | 11,580 | — | 33,334 |